Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cardiex Ltd
CDXCurrent price
0.11 AUD
+0.000000000076 AUD (+0.00%)
Last closed
0.11 AUD
Company
cardiex.com
ISIN
AU0000015729
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
39 431 095 AUD
Yield for 12 month
-13.07 %
1Y
3Y
5Y
10Y
15Y
CDX
CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia. Address: 55 Lime Street, Sydney, NSW, Australia, 2000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.76 AUDP/E ratio
–Dividend Yield
–Current Year
+10 828 051 AUD
Last Year
+4 571 528 AUD
Current Quarter
+1 207 508 AUD
Last Quarter
+1 207 508 AUD
Current Year
+10 035 854 AUD
Last Year
+3 672 124 AUD
Current Quarter
+982 292 AUD
Last Quarter
+982 292 AUD
Key Figures CDX
1 year
3 years
5 years
10 years
EBITDA
-4 528 147 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.31 %
PEG Ratio
–
Return On Equity TTM
-405.22 %
Wall Street Target Price
0.76 AUD
Revenue TTM
12 721 977 AUD
Book Value
0.014 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-35.6 %
Dividend Yield
–
Gross Profit TTM
4 751 309 AUD
Earnings per share
-0.03 AUD
Diluted Eps TTM
-0.03 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-52.8 %
Dividend Analytics CDX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
18.02.2022
Dividend Date
–
Stock Valuation CDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.5051
Price Sales TTM
2.8699
Enterprise Value EBITDA
-2.5315
Price Book MRQ
9.7159
Financials CDX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CDX
For 52 weeks
0.045 AUD
0.17 AUD
50 Day MA
0.075 AUD
Shares Short Prior Month
–
200 Day MA
0.071 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart